News

DelveInsight Business Research, LLP: Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer ...
The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...
The Scientist1d
Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies ...
American Association for the Advancement of Science (AAAS)2d
Immune Responses to Skin Microbiome Could Pave the Way for Novel Vaccination Responses
On the skin, millions of microbial colonists quietly coexist with their host as microscopic allies that help maintain health ...
AHA/ASA Journals2d
Anti-TRPV2 Autoantibody Linked to Sudden Infant Death Syndrome
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight ...
PharmiWeb3d
Global Custom Antibody Market Valuation and Growth Forecast to 2035
The global Custom Antibody Market is valued at USD 553.05 Million in 2024 and is projected to reach a value of USD 1237.1 ...
C&EN6d
The Interplay of Antigen Affinity, Internalization, and ...
Monoclonal antibodies (mAbs) offer promise as effective tumor targeting and drug delivery agents for cancer therapy. However, comparative biological and clinical characteristics of mAbs targeting the ...